Horizon Bancorp enters May with a notable divergence between what the data said two weeks ago and what it says now.
Short sellers have pulled back sharply. SI fell 18% over the past week to 2.6% of the free float — down from a recent peak above 3.2% in mid-April. That retreat followed a cluster of activity in early-to-mid April when positions built steadily. The reversal is clean: from April 20's 3.2% reading, shorts have unwound in four consecutive sessions. With borrow availability running above 7,000% of estimated short interest, the lending market is about as loose as it gets. Cost to borrow is a negligible 0.54% annually, though that's up roughly 40% from the week prior — still historically cheap. There is no squeeze pressure here; the dynamics favour shorts exiting at low friction.
Options positioning reinforces the low-anxiety read. The put/call ratio has drifted down to 0.08, well below its 20-day average of 0.12 and near the lower end of its year-long range (52-week low of 0.009, high of 0.73). That's a call-heavy skew — the options market is not loading up on downside protection ahead of the May 7 earnings date. The short score, at 34.6, has also eased from the 37 area seen earlier in April, reflecting the positioning unwind across both the borrow and derivatives markets.
Analyst coverage is cautiously constructive overall, though the most recent action trims targets. Piper Sandler held its Neutral rating on April 27 but cut its target to $21 from $22. Stephens assumed coverage in late March at Overweight with a $20 target, while Keefe, Bruyette & Woods raised its Outperform target to $21 in January following a solid Q4 print. The mean target of $21.20 implies roughly 18% upside from the current $17.91 — a gap that has grown as the stock added 10% over the past month. Bulls point to a potential ~50bps lift to return on assets and an improved balance sheet profile, projecting a total return around 26% in the base case. Bears flag slow loan growth in the low single digits, margin pressure from deposit repricing, rising expenses running 6-7% year-over-year, and higher provisioning needs. On valuation, the P/E has drifted to 8.4x — up modestly over the past month — while price-to-book is 1.17x, also higher. EPS momentum is firm at the 73rd percentile over 30 days, and the forward earnings growth rank holds at the 67th percentile.
Institutional ownership tells a steady accumulation story. BlackRock added 235,000 shares in the latest reported quarter to hold nearly 13% of shares. Vanguard added 176,000 shares to reach 6.2%. Jennison Associates showed the largest single addition — 510,000 shares — bringing their stake to 2.4%. State Street added 245,000. Against that backdrop, Wellington trimmed 150,000 shares. The net flow is directionally positive among the major holders.
Insider activity in March was unanimous selling — the President, two CFOs, and multiple EVPs all sold small tranches on March 18 and 23, realising prices between $15.71 and $16.28. Each transaction carried a significance score of 1 (the lowest), and none was material in dollar terms (the largest was $71,000). The 90-day net, however, shows net buying of $255,000 overall, suggesting the March sales were routine tax-related or plan-based disposals rather than a directional signal.
The next focal point is the May 7 earnings date. The stock's two most recent quarterly prints generated only modest day-one moves of around 0.7-1.6%, suggesting the market has not typically reacted strongly in either direction to HBNC results. Whether the Street's cautious target-trimming after Q1 turns into a full reset — or whether the improving ROA story gives bulls a fresh catalyst — is the question that earnings will answer.
See the live data behind this article on ORTEX.
Open HBNC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
